Detection and Characterization of RB1 Mosaicism in Patients With Retinoblastoma Receiving cfDNA Test.
Saved in:
| Title: | Detection and Characterization of RB1 Mosaicism in Patients With Retinoblastoma Receiving cfDNA Test. |
|---|---|
| Authors: | Gao C; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Patel J; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Robbins M; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York., Gedvilaite E; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Bowman AS; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Arora K; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Vanderbilt C; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Brannon AR; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Friedman DN; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York., Kennedy J; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Fiala E; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Ceyhan-Birsoy O; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Dunkel IJ; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York., Weigelt B; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Francis JH; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Ophthalmology, Weill Cornell Medical Center, New York, New York., Reis-Filho JS; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Cancer Biomarker Development, Oncology Research and Development, AstraZeneca, Gaithersburg, Maryland., Abramson DH; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Ophthalmology, Weill Cornell Medical Center, New York, New York., Mandelker D; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. |
| Source: | JAMA ophthalmology [JAMA Ophthalmol] 2025 Jul 01; Vol. 143 (7), pp. 562-568. |
| Publication Type: | Journal Article; Comment |
| Journal Info: | Publisher: American Medical Association Country of Publication: United States NLM ID: 101589539 Publication Model: Print Cited Medium: Internet ISSN: 2168-6173 (Electronic) Linking ISSN: 21686165 NLM ISO Abbreviation: JAMA Ophthalmol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2168-6173 |
|---|---|
| DOI: | 10.1001/jamaophthalmol.2025.1079 |
